Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

464 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Fecal Microbiota Transplantation from Mice Receiving Magnetic Mitohormesis Treatment Reverses High-Fat Diet-Induced Metabolic and Osteogenic Dysfunction.
Wong JKC, Patel BK, Tai YK, Tan TZ, Khine WWT, Chen WC, Kukumberg M, Ching J, Lee LS, Chua KV, Tan TY, Wu KY, Bai X, Iversen JN, Purnamawati K, Abdul Jalil R, Kumar AP, Lee YK, Moochhala SM, Franco-Obregón A. Wong JKC, et al. Among authors: kumar ap. Int J Mol Sci. 2025 Jun 6;26(12):5450. doi: 10.3390/ijms26125450. Int J Mol Sci. 2025. PMID: 40564914 Free PMC article.
A festschrift in honor of Ian M. Thompson Jr., MD.
Svatek RS, Ankerst DP, D' Amico AV, Flaig TW, Ford LG, Goldkorn A, Hernandez J, Kumar AP, Leach RJ, Lerner S, Liss MA, McConkey DJ, Minasian L, Morilak D, Mueller EJ, Parekh DJ, Platz EA, Sudarshan S, Unger JM. Svatek RS, et al. Among authors: kumar ap. Urol Oncol. 2025 Jul;43(7):423-435. doi: 10.1016/j.urolonc.2024.10.030. Epub 2025 May 16. Urol Oncol. 2025. PMID: 40447392 No abstract available.
Cell cycle dysregulation in cancer.
Glaviano A, Singh SK, Lee EHC, Okina E, Lam HY, Carbone D, Reddy EP, O'Connor MJ, Koff A, Singh G, Stebbing J, Sethi G, Crasta KC, Diana P, Keyomarsi K, Yaffe MB, Wander SA, Bardia A, Kumar AP. Glaviano A, et al. Among authors: kumar ap. Pharmacol Rev. 2025 Mar;77(2):100030. doi: 10.1016/j.pharmr.2024.100030. Epub 2024 Dec 24. Pharmacol Rev. 2025. PMID: 40148026 Review.
Bispecific antibodies as powerful immunotherapeutic agents for urological cancers: Recent innovations based on preclinical and clinical evidence.
Hushmandi K, Einollahi B, Lee EHC, Sakaizawa R, Glaviano A, Reiter RJ, Saadat SH, Farani MR, Huh YS, Aref AR, Salimimoghadam S, Kumar AP. Hushmandi K, et al. Among authors: kumar ap. Int J Biol Sci. 2025 Jan 27;21(4):1410-1435. doi: 10.7150/ijbs.96155. eCollection 2025. Int J Biol Sci. 2025. PMID: 39990653 Free PMC article. Review.
Epigenetic Control of Redox Pathways in Cancer Progression.
Shah V, Lam HY, Leong CH, Sakaizawa R, Shah JS, Kumar AP. Shah V, et al. Among authors: kumar ap. Antioxid Redox Signal. 2025 Jun;42(16-18):848-867. doi: 10.1089/ars.2023.0465. Epub 2025 Jan 16. Antioxid Redox Signal. 2025. PMID: 39815993 Review.
464 results